Skip to main content

Advertisement

Table 1 Table

From: Experience with pediatric sarcoidosis at a centre in Mumbai, India

Cohort features Characteristics at Onset/ 1st visit Follow-up ( ≥ 1 year)
Number(N) Median age (years) [IQR] 12 Onset:1.25[0.9-1.7]Diagnosis:7.8[4.9-9.9] 8
Fever; median duration 10/12(83.3%);18 months Resolution
Arthritis 7/12(58.3%) Resolution
Skin manifestations 7/12(58.3%) Resolved 6/8(75%)
Ocular abnormalities Onset: 6/12(50%), 1st visit: 5/6(83.3%) 2/5(40%)
Triad-Arthritis,Rash,Uveitis Onset: 5/12(41.7%), 1st visit: 3/5(60%) None
Systemic features Sicca(1),Adenopathy(4),GIT(4), Pulmonary(5), Organomegaly(9) Aortoarteritis(1/8) Interstitial lung(1/8)
Growth retardation 12/12(100%) 5/8(62.5%)
Median Steroid dose(mg/kg/day) [IQR] Median Methotrexate dose(mg/m2BSA) [IQR] Others: 0.6[0.2-0.8] 10.1[0-10.4] 0.3[0.1-0.3] 10.9[9.7-15.3] Azathioprine(vasculitic rash)(1),Mycophenolate(uveitis)(1)
Treatment side-effects - Hepatotoxicity(1/8) Osteoporosis(2/8) Cataracts(3/8)